Leadership Team

Successful Track Record in Drug Approvals: Translating Science into Commercial Products

Track record and experience are key drivers of success in drug development. Our experienced, multi-disciplinary team have overseen successful new drug application (NDA) programs. Some have built, scaled and exited drug development companies. Others have supported major M&A and licensing transactions across the sector. This experience has all been instrumental in building our risk-adjusted portfolio and will drive continued development and value creation.

Board of Directors

Brian Gallagher, Jr.

Chairman

Dr Clare Wareing

Founder & CEO

Mr Keith Murdoch

NED

Catherine Lewis La Torre

NED

Dr Andrew McNeill

Investor Director

Manuel Aivado

NED

Team

Dr Clare Wareing

Founder & CEO

Clare Doris

Chief Development Officer

James Fair

Chief Financial Officer

Scott Doak

Group Finance Director

Dr Dominic James

Executive in Residence

Dr Tilly Bingham

Executive in Residence

Laura Gallagher

Senior Operations Lead (Program Management)

Brian Jones

Scientific Advisor

Currently hiring

Get in touch if you have what it takes to join our team

Contact Us

For more information on our pipeline or individual programmes please get in touch with us